URM includes a mandate for manuscripts describing human interventional trials to register a trial in a clinical trial registry (e.g., ClinicalTrials.gov) and to include the trial registration ID in the abstract of the article. The URM also requires that this registration is done prior enrolling the first participant. A study of five high impact factor journals (founders of
ICMJE) showed that only 89% of published articles (articles published during 2010–2011; about trials that completed in 2008) were properly registered prior enrolling the first participant. A 2016 draft proposal to require that manuscript authors disclose individual patient data relevant to published outcomes within six months of reporting a clinical trial was successfully opposed by
Jeffrey M. Drazen, then editor-in-chief of
The New England Journal of Medicine. Drazen's claim that "'a new class of research person will emerge,' one who might 'even use the data to try to disprove what the original investigators had posited'" was criticized as protecting intentionally deceptive biomedical researchers. ==Disclosure of competing interests==